Bath & Body Works (NYSE:BBWI) Issues FY25 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $3.06-3.26 for the period, compared to the consensus earnings per share estimate of $3.19. The company issued revenue guidance of down 2-4% yr/yr to ~$7.13-7.28 billion, compared to the consensus revenue estimate of $7.25 billion. Bath & Body Works also updated its Q3 guidance to $0.41-0.47 EPS.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $31.74 on Friday. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The company’s fifty day moving average price is $31.96 and its two-hundred day moving average price is $40.40. The company has a market capitalization of $6.95 billion, a price-to-earnings ratio of 8.18, a PEG ratio of 0.96 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. As a group, sell-side analysts anticipate that Bath & Body Works will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were paid a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 dividend on an annualized basis and a yield of 2.52%. Bath & Body Works’s payout ratio is presently 20.62%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on BBWI shares. Evercore ISI decreased their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an in-line rating for the company in a report on Wednesday, August 28th. Robert W. Baird lowered their target price on Bath & Body Works from $54.00 to $45.00 and set an outperform rating on the stock in a report on Thursday, August 29th. Citigroup cut their price target on Bath & Body Works from $48.00 to $35.00 and set a neutral rating for the company in a report on Tuesday, August 20th. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $56.00 to $51.00 and set an overweight rating on the stock in a research note on Thursday, September 5th. Finally, UBS Group cut their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a neutral rating for the company in a research note on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of Moderate Buy and a consensus target price of $42.35.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.